1.Richardson, WS, Wilson, M, Guyatt, GH.The process of diagnosis. In: Guyatt, G, Rennie, D.The users’ guide to the medical literature: a manual for evidence-based clinical practice. Chicago (IL): American Medical Association; 2002. p. 155–67.
2.Morrow, DA, Antman, EM, Tanasijevic, M, Rifai, N, de Lemos, JA, McCabe, CH, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 2000;36:1812–7.
3.Antman, EM, Tanasijevic, MJ, Thompson, B, Schactman, M, Mc-Cabe, CH, Cannon, CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342–9.
4.Lindahl, B, Toss, H, Siegbahn, A, Venge, P, Wallentin, L.Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000;343:1139–47.
5.DeFilippi, CR, Tocchi, M, Parmar, RJ, Rosanio, S, Abreo, G, Potter, MA, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol 2000;35:1827–34.
6.Tanasijevic, MJ, Cannon, CP, Antman, EM.The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Chem Biol 1999;22:13–6.
7.Christenson, RH.Evidence based approach to practice guides and decision thresholds for cardiac markers. Scand J Clin Lab Invest 1999;230:90–102.
8.Möckel, M, Störk, T, Heller, G, Röcker, OD, Darrelmann, K, Eichstädt, H, et al. Troponin T in patients with low grade or atypical angina. Eur Heart J 1998;19:1802–7.
9.Heidenreich, PA, Alloggiamento, T, Melsop, K, McDonald, KM, Go, AS, Hlatky, MA.The prognostic value of troponin in patients with non-ST elevation acute coronary artery syndromes: a metaanalysis. J Am Coll Cardiol 2001;38:478–85.
10.Green, GB, Beaudreau, RW, Chan, DW, DeLong, D, Kelly, CA, Gabor, KD.Use of troponin T and creatine kinase-MB subunit levels for risk stratification of emergency department patients with possible myocardial ischemia. Ann Emerg Med 1998;31:19–29.
11.Hamm, CW, Goldman, BU, Heeschen, C, Kreyman, G, Berger, J, Meinertz, T.Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648–53.
12.Limkakeng, A, Gibler, WB, Pollack, C, Hoekstra, JW, Sites, F, Shofer, FS, et al. Combination of Goldman risk and initial cardiac troponin I for emergency department chest pain patient risk stratification. Acad Emerg Med 2001;8:696–702.
13.Kontos, M, Anderson, FP, Alimard, R, Ornato, JP, Tatum, JL, Jesse, RL.Ability of troponin I to predict cardiac events in patients admitted from the emergency department. J Am Coll Cardiol 2000;36:1818–23.
14.Polanczyk, CA, Lee, TH, Cook, EF, Walls, R, Wybenga, D, Printy-Klein, G, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998;32:8–14.
15.Zarich, S, Bradley, K, Seymour, J, Wael, G, Traboulsi, A, Mayall, ID, et al. Impact of troponin T determinations on hospital resource utilization and costs in the evaluation of patients with suspected myocardial ischemia. Am J Cardiol 2001;88:732–6.
16.Hamm, CW, Ravkilde, J, Gerhardt, W, Jorgensen, P, Pedheim, E, Ljungdahl, L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146–50.
17.Hetlund, O, Dickstein, K.Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin T. Scand J Lab Invest 1996;56:701–13.
18.Ebell, MH, Flewelling, D, Flynn, CA.A systematic review of troponin T and troponin I for diagnosing acute myocardial infarction. J Fam Pract 2000;49:550–6.
19.Ellestad, MH, Starr-Selvester, R, Stanon, E, VanNatta, B, Ahmad, J, Swinger, F.The utility of four biochemical markers in the triage of chest pain patients. Cardiology 2000;933:242–8.
20.Taylor, C, Forrest-Hay, A, Meek, S.ROMEO: a rapid rule out strategy for low risk chest pain. Does it work in a UK emergency department? Emerg Med J 2002;19:395–9.
21.Missov, E, Calzolari, C, Pau, B.Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953–8.
22.Missov, E, DeMarco, T.Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta 1999;284: 175–85.
23.Setsuta, K, Seino, Y, Takahashi, N, Ogawa, T, Sasaki, K, Harada, A, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999;84:608–11.
24.Worster, A, Innes, G, Abu-Laban, RB.Diagnostic testing: an emergency medicine perspective. Can J Emerg Med 2002; 4(5):348–54.
25.Braunwald, E, Mark, DB, Jones, RH, Brown, J, Brown, L, Cheitlin, MD, et al. Unstable angina: diagnosis and management. Clinical practice guideline number 10. AHCPR publication no. 94-0606. Rockville (MD): Agency for Health Care Policy and Research and the National Heart, Lung and Blood Institute, Public Health Service, US Department of Health and Human Services; 1994 (amended).
26.Gillum, RF, Fortmann, SP, Prineas, RJ, Kottke, TE.International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150–8.
27.Ontario Medical Association Quality Management Program — Laboratory Services. Enzymes, Cardiac Markers and Lipids Committee Comment. Toronto: The Association; 2002. p. 122–3.
28.Pagani, F, Yeo, J, Apple, F, Christenson, R, Dati, F, Mair, J, et al. Evaluation of the imprecision at the low-range concentration of the assays for cardiac troponin determination. Clin Chem 2003;49(suppl):A34.
29.Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959–69.